Why Embrace Learning Empowerment in Biopharma? Insights from 3PBIOVIAN’s Talent Development JourneyJuly 21, 2025Read more >
Why Embrace Diversity, Equity, And Inclusion (DEI) In The CDMO/Biopharma Sector: Insights From 3PBIOVIAN’s JourneyJune 24, 2025Read more >
Elena Erroba Assumes Representation of 3PBIOVIAN on the AseBio Board of DirectorsMay 27, 2025Read more >
3PBIOVIAN Unveils Two Groundbreaking Technology Platforms for AAV and pDNA Manufacturing May 13, 2025Read more >
3PBIOVIAN Awarded at the CDMO Leadership Awards 2025 in the Cell & Gene Therapy International Category April 1, 2025Read more >
3PBIOVIAN Celebrates Its First Anniversary Leading the Future of BiotechnologyFebruary 12, 2025Read more >